HK Stock Market Move | INNOSCIENCE(02577) rose more than 3% and was included in the FTSE Global Equity Index Series. Policies are driving the scale preparation and application of gallium nitride and other materials.

date
10:02 12/03/2026
avatar
GMT Eight
Innovent Biologics (02577) rose over 3%, as of the deadline, up 3.03% to 64.7 Hong Kong dollars, with a turnover of 1.24 billion Hong Kong dollars.
INNOSCIENCE (02577) rose more than 3%, as of press time, up 3.03% to HKD 64.7, with a turnover of HKD 1.24 billion. On the news front, on March 10, INNOSCIENCE announced that the company has been included in the FTSE Russell's FTSE Global Equity Index Series, including the FTSE Global Large Cap Index, FTSE Global Stock Index (Large and Mid Cap), FTSE Global Equity Index (Large, Mid, and Small Cap), and FTSE Total Equity Index (Large, Mid, Small, and Micro Cap). The inclusion will take effect after the close of trading on March 20, 2026. The board believes that the company's inclusion in the FTSE Global Equity Index Series signifies recognition of the company's investment value in the international capital market and is expected to attract passive fund allocations, bringing stable incremental funds to the company. Of note, on March 10, the General Office of the People's Government of Guangdong Province issued the "Action Plan for Accelerating the Cultivation and Development of New Tracks to Lead the Construction of Modern Industrial System (2026-2035)." It proposes to promote the scale preparation and application of materials such as silicon carbide and gallium nitride, conduct research on materials and preparation technologies such as gallium oxide, aluminum nitride, and diamond, promote advanced manufacturing processes such as FD-SOI and heterogeneous integration, and advance photonic-hybrid integration and other advanced packaging technologies. Public information shows that INNOSCIENCE has established a base in the Zhuhai High-Tech Zone, which has rare full-process capabilities in gallium nitride IDM domestically.